reviewBiomedicine & PharmacotherapyFeb 18, 2019GOLD OA

The role of m6A RNA methylation in cancer

First Affiliated Hospital of Zhengzhou University · Fudan University Shanghai Cancer Center

PubMed
Indexed incrossrefdoajpubmed

Abstract

N6-methyladenosine (m6A), the most abundant internal modification of RNA in eukaryotic cells, has gained increasing attention in recent years. The m6A modification affects multiple aspects of RNA metabolism, ranging from RNA processing, nuclear export, RNA translation to decay. Emerging evidence suggests that m6A methylation plays a critical role in cancer through various mechanisms. Moreover, m6A methylation has provided more possibilities for the early diagnosis and treatment of cancers. In this review, we focus on m6A-associated mechanisms and functions in several major malignancies and summarize the dual role of m6A methylation as well as its prospects in cancer.

Citation impact

1,061
total citations
FWCI
43.85
Percentile
100%
References
113
Citations per year

Authors

3

Topics & keywords

Keywords
  • RNA methylation
  • RNA
  • Methylation
  • Biology
  • Translation (biology)
  • N6-Methyladenosine
  • Cancer research
  • Computational biology
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding